Brain-sparing methods for IMRT of head and neck cancer.
Radical radiotherapy for head and neck cancer (HNC) may deliver significant doses to brain structures. There is evidence that this may cause a decline in neurocognitive function (NCF). Radiation dose to the medial temporal lobes, and particularly to the hippocampi, seems to be critical in determinin...
Main Authors: | Alex Dunlop, Liam Welsh, Dualta McQuaid, Jamie Dean, Sarah Gulliford, Vibeke Hansen, Shreerang Bhide, Chris Nutting, Kevin Harrington, Kate Newbold |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4364536?pdf=render |
Similar Items
-
Inter-Observer Variation in Delineating the Pharyngeal Constrictor Muscle as Organ at Risk in Radiotherapy for Head and Neck Cancer
by: Imran Petkar, et al.
Published: (2021-03-01) -
Incorporating spatial dose metrics in machine learning-based normal tissue complication probability (NTCP) models of severe acute dysphagia resulting from head and neck radiotherapy
by: Jamie Dean, et al.
Published: (2018-01-01) -
Parotid gland sparing IMRT for head and neck cancer improves xerostomia related quality of life
by: Balm AJM, et al.
Published: (2008-12-01) -
Early-Stage Glottic Squamous Cell Carcinoma in the Era of Image-Guided Radiotherapy
by: Amit Gupta, et al.
Published: (2021-09-01) -
Postoperative IMRT in head and neck cancer
by: Zwahlen Roger A, et al.
Published: (2006-10-01)